Template:Catecholaminergic polymorphic ventricular tachycardia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
''' | '''Catecholaminergic polymorphic ventricular tachycardia Microchapters''' | ||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
! | ! | ||
Line 9: | Line 9: | ||
|- bgcolor="LightCoral" | |- bgcolor="LightCoral" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia|Home]] | ||
|- | |- | ||
! | ! | ||
Line 15: | Line 15: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia(patient information)|Patient Information]] | ||
|- | |- | ||
! | ! | ||
Line 21: | Line 21: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia overview|Overview]] | ||
|- | |- | ||
! | ! | ||
Line 27: | Line 27: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia historical perspective|Historical Perspective]] | ||
|- | |- | ||
! | ! | ||
Line 33: | Line 33: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia classification|Classification]] | ||
|- | |- | ||
! | ! | ||
Line 39: | Line 39: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia pathophysiology|Pathophysiology]] | ||
|- | |- | ||
! | ! | ||
Line 45: | Line 45: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia causes|Causes]] | ||
|- | |- | ||
! | ! | ||
Line 51: | Line 51: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia differential diagnosis|Differentiating Xyz from other Diseases]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
Line 62: | Line 62: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
Line 68: | Line 68: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia screening|Screening]] | ||
|- | |- | ||
! | ! | ||
Line 74: | Line 74: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia natural history, complications and prognosis|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
Line 86: | Line 86: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia diagnostic study of choice|Diagnostic Study of Choice]] | ||
|- | |- | ||
! | ! | ||
Line 92: | Line 92: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia history and symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
Line 98: | Line 98: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia physical examination|Physical Examination]] | ||
|- | |- | ||
! | ! | ||
Line 104: | Line 104: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia laboratory findings|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
Line 110: | Line 110: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia electrocardiogram|Electrocardiogram]] | ||
|- | |- | ||
! | ! | ||
Line 116: | Line 116: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia x ray|X-ray]] | ||
|- | |- | ||
! | ! | ||
Line 122: | Line 122: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia echocardiography and ultrasound|Echocardiography and Ultrasound]] | ||
|- | |- | ||
! | ! | ||
Line 128: | Line 128: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia CT scan|CT scan]] | ||
|- | |- | ||
! | ! | ||
Line 134: | Line 134: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia MRI|MRI]] | ||
|- | |- | ||
! | ! | ||
Line 140: | Line 140: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia other imaging findings|Other Imaging Findings]] | ||
|- | |- | ||
! | ! | ||
Line 146: | Line 146: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia other diagnostic studies|Other Diagnostic Studies]] | ||
|- | |- | ||
! | ! | ||
Line 158: | Line 158: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia medical therapy|Medical Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 164: | Line 164: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia interventions|Interventions]] | ||
|- | |- | ||
! | ! | ||
Line 170: | Line 170: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia surgery|Surgery]] | ||
|- | |- | ||
! | ! | ||
Line 176: | Line 176: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia primary prevention|Primary Prevention]] | ||
|- | |- | ||
! | ! | ||
Line 182: | Line 182: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia secondary prevention|Secondary Prevention]] | ||
|- | |- | ||
! | ! | ||
Line 188: | Line 188: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 194: | Line 194: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia future or investigational therapies|Future or Investigational Therapies]] | ||
|- | |- | ||
! | ! | ||
Line 206: | Line 206: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ | [[Catecholaminergic polymorphic ventricular tachycardia case study one|Case #1]] | ||
|- | |- | ||
! | ! |
Revision as of 16:44, 22 July 2020
Catecholaminergic polymorphic ventricular tachycardia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Catecholaminergic polymorphic ventricular tachycardia On the Web |
American Roentgen Ray Society Images of Catecholaminergic polymorphic ventricular tachycardia |
FDA on Catecholaminergic polymorphic ventricular tachycardia |
CDC on Catecholaminergic polymorphic ventricular tachycardia |
Catecholaminergic polymorphic ventricular tachycardia in the news |
Blogs on Catecholaminergic polymorphic ventricular tachycardia |
Risk calculators and risk factors for Catecholaminergic polymorphic ventricular tachycardia |